PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines
McCubrey, James A.. (February 2017).
PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/9623
McCubrey, James A..
"PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines". .
. (),
February 2017.
January 30, 2023.
http://hdl.handle.net/10342/9623.
Chicago:
McCubrey, James A.,
"PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines," , no.
(February 2017),
http://hdl.handle.net/10342/9623 (accessed
January 30, 2023).
AMA:
McCubrey, James A..
PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines. .
February 2017;
():
.
http://hdl.handle.net/10342/9623. Accessed
January 30, 2023.
